This effect seems to even endure the elevated demand for muscle regenerative activity caused by dystrophin-deficiency, as suggested by the higher relative suppression of circulating myostatin levels in mdx mice (25%) versus DMD patients (8%) compared to healthy controls [4]. This evidence concerns the gene MSTN and Duchenne muscular dystrophy.